CORD-19:00a0ab182dc01b6c2e737dfae585f050dcf9a7a5 / 105336-105921 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T39","span":{"begin":0,"end":585},"obj":"Sentence"}],"text":"Characteristics including the higher PFC among MERS cases (above 50% in 2013 and currently at 30-40%; well above the 9.5% of SARS), the association between fatal disease and older males with underlying comorbidities, the very broad tropism of MERS-CoV, its rapid in vitro growth, rapid induction of cytopathogenic change, robust yet distinct transcriptional responses, use of a different receptor, its induction of a more proinflammatory but reduced and delayed innate antiviral response and its sensitivity to external IFN␣ or IFN␤ all signal differences from SARS-CoV to some degree."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T552","span":{"begin":0,"end":585},"obj":"Sentence"},{"id":"T23055","span":{"begin":0,"end":585},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Characteristics including the higher PFC among MERS cases (above 50% in 2013 and currently at 30-40%; well above the 9.5% of SARS), the association between fatal disease and older males with underlying comorbidities, the very broad tropism of MERS-CoV, its rapid in vitro growth, rapid induction of cytopathogenic change, robust yet distinct transcriptional responses, use of a different receptor, its induction of a more proinflammatory but reduced and delayed innate antiviral response and its sensitivity to external IFN␣ or IFN␤ all signal differences from SARS-CoV to some degree."}

{"project":"Epistemic_Statements","denotations":[{"id":"T242","span":{"begin":0,"end":585},"obj":"Epistemic_statement"}],"text":"Characteristics including the higher PFC among MERS cases (above 50% in 2013 and currently at 30-40%; well above the 9.5% of SARS), the association between fatal disease and older males with underlying comorbidities, the very broad tropism of MERS-CoV, its rapid in vitro growth, rapid induction of cytopathogenic change, robust yet distinct transcriptional responses, use of a different receptor, its induction of a more proinflammatory but reduced and delayed innate antiviral response and its sensitivity to external IFN␣ or IFN␤ all signal differences from SARS-CoV to some degree."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T371","span":{"begin":125,"end":129},"obj":"Disease"},{"id":"T372","span":{"begin":561,"end":569},"obj":"Disease"},{"id":"T373","span":{"begin":561,"end":565},"obj":"Disease"}],"attributes":[{"id":"A371","pred":"mondo_id","subj":"T371","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A372","pred":"mondo_id","subj":"T372","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A373","pred":"mondo_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Characteristics including the higher PFC among MERS cases (above 50% in 2013 and currently at 30-40%; well above the 9.5% of SARS), the association between fatal disease and older males with underlying comorbidities, the very broad tropism of MERS-CoV, its rapid in vitro growth, rapid induction of cytopathogenic change, robust yet distinct transcriptional responses, use of a different receptor, its induction of a more proinflammatory but reduced and delayed innate antiviral response and its sensitivity to external IFN␣ or IFN␤ all signal differences from SARS-CoV to some degree."}